Incyte (INCY) Stock Insights

INCY price $117.22 +0.62 +0.54%

Ticker
INCY
Price
$117.22
Change
+0.62 +0.54%
Market cap ?
$23.76B
P/E ?
13.94
Forward P/E ?
36.91
Dividend yield ?
0.00%
Beta ?
0.74
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
76
Value
64
Quality
95
Growth
68

Stocklytics score rationale: value 64, quality 95, growth 68.

Financials

2016201720182019202020212022202320242025
1105719000153621600018818830002158759000266670200029862670003394635000369564900042412170005141242000

Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for…

Fair value

INCY fair value $215.78. Price $117.22. Price is 46% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 71% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.92B. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 202.70M. Net debt -3.03B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare INCY

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—-3.93—1.46B
2026-07-283.092.151.67B1.50B
2026-04-281.811.341.27B1.22B
2026-02-101.801.901.51B1.35B
2025-10-282.261.661.37B1.35B
2025-07-291.571.391.22B1.26B
2025-04-291.161.011.05B1.15B
2025-02-101.431.571.18B1.00B
2024-10-291.071.121.14B1.14B
2024-07-30-1.820.781.04B1.03B
2024-04-300.640.84880.89M921.89M
2024-02-131.061.161.01B1.00B
2023-10-311.101.09919.02M966.90M
2023-08-010.990.83954.61M910.25M
2023-05-020.370.56808.67M859.17M
2023-02-070.620.58926.70M878.25M
2022-11-010.600.72823.30M842.66M
2022-08-021.010.79911.40M818.49M
2022-05-030.550.57733.24M749.98M
2022-02-080.100.84862.85M812.44M
2021-11-021.180.76812.99M548.77M
2021-08-030.800.74705.71M685.88M
2021-05-040.670.65604.72M656.80M
2021-02-090.930.82789.51M662.71M
2020-11-050.230.72620.64M2.02B
2020-08-041.240.87688.04M482.74M
2020-05-05-2.860.08568.51M121.25M
2020-02-130.650.57579.39M508.08M
2019-10-290.820.65551.58M437.23M
2019-07-300.750.49529.93M339.16M
2019-04-300.620.40497.86M321.20M
2019-02-140.400.46528.40M607.66M
2018-10-300.380.40449.68M473.35M
2018-07-310.260.34521.52M702.02M
2018-05-01-0.01-0.00382.28M1.53B
2018-02-150.02-0.52444.16M275.28M
2017-10-310.170.06381.53M157.09M
2017-08-01-0.06-0.05326.44M272.00M
2017-05-04-0.96-0.97384.08M400.10M
2017-02-140.150.14326.50M848.90M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15CAGNONI PABLO JBuy925$64.2559.43K
2026-10-15CAGNONI PABLO JBuy455$61.1827.84K
2026-10-15CAGNONI PABLO JBuy423$61.7626.12K
2026-10-15CAGNONI PABLO JBuy839$71.9360.35K
2026-10-15CAGNONI PABLO JSell2.64K$112.71297.78K
2026-10-15CAGNONI PABLO JSell925$64.2559.43K
2026-10-15CAGNONI PABLO JSell839$71.9360.35K
2026-10-15CAGNONI PABLO JSell455$61.1827.84K
2026-10-15CAGNONI PABLO JSell423$61.7626.12K
2026-10-01Heeson LeeSell463$117.1454.24K
2026-09-30BAKER BROS. ADVISORS LPBuy322——
2026-09-30BAKER BROS. ADVISORS LPBuy322——
2026-09-30Clancy Paul JBuy203$121.3524.63K
2026-09-30HARRIGAN EDMUNDBuy206$121.3525.00K
2026-09-22Gardner David HSell920$126.93116.78K
2026-09-15CAGNONI PABLO JBuy9.23K$71.93664.13K
2026-09-15CAGNONI PABLO JSell9.23K$120.501.11M
2026-09-15CAGNONI PABLO JBuy6.48K$64.25416.15K
2026-09-15CAGNONI PABLO JBuy4.55K$61.18278.43K
2026-09-15CAGNONI PABLO JBuy2.96K$61.76182.62K
2026-09-15CAGNONI PABLO JSell13.98K$120.491.69M
2026-09-15CAGNONI PABLO JSell6.48K$64.25416.15K
2026-09-15CAGNONI PABLO JSell9.23K$71.93664.13K
2026-09-15CAGNONI PABLO JSell4.55K$61.18278.43K
2026-09-15CAGNONI PABLO JSell2.96K$61.76182.62K
2026-08-25Basi Ramitpal KSell504$129.7265.38K
2026-08-19CAGNONI PABLO JSell10.80K$125.561.36M
2026-08-12CAGNONI PABLO JSell10.80K$120.041.30M
2026-08-05CAGNONI PABLO JSell10.64K$122.691.31M
2026-08-05Mayes Patrick ABuy2.21K$106.47234.98K
2026-08-05Mayes Patrick ASell2.21K$123.99273.65K
2026-08-05Mayes Patrick ASell2.21K$106.47234.98K
2026-08-03Mayes Patrick ABuy6.05K$105.43638.38K
2026-08-03Mayes Patrick ASell6.05K$120.43729.20K
2026-08-03Mayes Patrick ASell6.05K$105.43638.38K
2026-07-31CAGNONI PABLO JSell15.89K$119.701.90M
2026-07-31Mayes Patrick ABuy326$105.4334.37K
2026-07-31Mayes Patrick ABuy85$106.479.05K
2026-07-31Mayes Patrick ABuy2.29K$90.56207.65K
2026-07-31Mayes Patrick ABuy1.64K$85.01139.59K
2026-07-31Mayes Patrick ABuy2.62K$83.58219.23K
2026-07-31Mayes Patrick ABuy3.02K$83.20251.51K
2026-07-31Mayes Patrick ABuy1.64K$80.50132.26K
2026-07-31Mayes Patrick ABuy2.86K$77.67222.45K
2026-07-31Mayes Patrick ABuy2.62K$74.78196.15K
2026-07-31Mayes Patrick ASell14.66K$119.461.75M
2026-07-31Mayes Patrick ABuy9.46K$72.27683.60K
2026-07-31Mayes Patrick ASell5.33K$119.42636.75K
2026-07-31Mayes Patrick ASell2.19K$119.47261.28K
2026-07-31Mayes Patrick ABuy2.07K$71.93149.04K
2026-07-31Mayes Patrick ASell6.17K$119.43737.00K
2026-07-31Mayes Patrick ABuy3.15K$68.62216.02K
2026-07-31Mayes Patrick ABuy2.71K$61.76167.31K
2026-07-31Mayes Patrick ASell4.70K$119.39560.54K
2026-07-31Mayes Patrick ABuy2.28K$64.25146.75K
2026-07-31Mayes Patrick ASell2.86K$119.40341.96K
2026-07-31Mayes Patrick ABuy2.92K$61.18178.52K
2026-07-31Mayes Patrick ASell1.64K$119.51196.35K
2026-07-31Mayes Patrick ASell1.64K$119.38196.02K
2026-07-31Mayes Patrick ASell85$122.1910.39K
2026-07-31Mayes Patrick ASell326$121.6939.67K
2026-07-31Mayes Patrick ASell2.29K$119.41273.81K
2026-07-31Mayes Patrick ASell326$105.4334.37K
2026-07-31Mayes Patrick ASell2.28K$64.25146.75K
2026-07-31Mayes Patrick ASell2.07K$71.93149.04K
2026-07-31Mayes Patrick ASell85$106.479.05K
2026-07-31Mayes Patrick ASell2.92K$61.18178.52K
2026-07-31Mayes Patrick ASell2.71K$61.76167.31K
2026-07-31Mayes Patrick ASell3.02K$83.20251.51K
2026-07-31Mayes Patrick ASell2.86K$77.67222.45K
2026-07-31Mayes Patrick ASell1.64K$85.01139.59K
2026-07-31Mayes Patrick ASell2.29K$90.56207.65K
2026-07-31Mayes Patrick ASell3.15K$68.62216.02K
2026-07-31Mayes Patrick ASell9.46K$72.27683.60K
2026-07-31Mayes Patrick ASell2.62K$74.78196.15K
2026-07-31Mayes Patrick ASell1.64K$80.50132.26K
2026-07-31Mayes Patrick ASell2.62K$83.58219.23K
2026-07-23Morrissey Michael JamesBuy9.00K——
2026-07-23Morrissey Michael JamesBuy6.43K$116.69749.85K
2026-07-23Heeson LeeBuy15.42K$116.691.80M
2026-07-23Heeson LeeBuy13.50K——
2026-07-16Tray ThomasBuy2.83K——
2026-07-16Tray ThomasBuy4.08K$116.65475.82K
2026-07-16Stein Steven HBuy42.30K$116.654.93M
2026-07-16Stein Steven HBuy9.80K——
2026-07-16Stein Steven HBuy24.50K——
2026-07-16Stein Steven HSell1.88K$114.73215.35K
2026-07-16Mayes Patrick ABuy5.92K——
2026-07-16Mayes Patrick ABuy25.54K$116.652.98M
2026-07-16Mayes Patrick ABuy14.79K——
2026-07-16CAGNONI PABLO JBuy13.40K——
2026-07-16CAGNONI PABLO JBuy57.86K$116.656.75M
2026-07-16CAGNONI PABLO JBuy33.51K——
2026-07-16Issa Mohamed KhairieBuy7.86K——
2026-07-16Issa Mohamed KhairieSell1.09K$115.01125.71K
2026-07-16Issa Mohamed KhairieBuy33.92K$116.653.96M
2026-07-16Issa Mohamed KhairieBuy19.64K——
2026-07-16Basi Ramitpal KBuy21.55K$116.652.51M
2026-07-16Basi Ramitpal KBuy12.48K——
2026-07-16Basi Ramitpal KBuy4.99K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 881, holders +40 vs prior quarter. Ownership 102.64%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP30.76M17.92K+0.06%3.49B
BLACKROCK, INC.18.03M-945.48K-4.98%2.04B
DODGE & COX11.96M-295.03K-2.41%1.36B
VANGUARD CAPITAL MANAGEMENT LLC11.02M94.22K+0.86%1.25B
STATE STREET CORP9.72M80.95K+0.84%1.10B
VANGUARD PORTFOLIO MANAGEMENT LLC7.79M31.91K+0.41%883.20M
AQR CAPITAL MANAGEMENT LLC5.32M-487.03K-8.39%603.18M
GEODE CAPITAL MANAGEMENT, LLC4.75M47.55K+1.01%536.52M
LSV ASSET MANAGEMENT4.12M203.70K+5.20%467.47M
INVESCO LTD.4.08M209.70K+5.42%462.56M
WELLINGTON MANAGEMENT GROUP LLP3.58M309.38K+9.47%405.32M
RENAISSANCE TECHNOLOGIES LLC3.51M-139.40K-3.82%398.14M
MORGAN STANLEY2.95M98.04K+3.44%334.23M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.74M-85.84K-3.03%311.17M
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V.2.44M-72.65K-2.89%276.80M
GOLDMAN SACHS GROUP INC2.31M-45.44K-1.93%261.38M
DIMENSIONAL FUND ADVISORS LP2.28M305.26K+15.45%258.59M
TWO SIGMA INVESTMENTS, LP2.00M1.59M+381.72%227.12M
NORTHERN TRUST CORP1.76M-87.76K-4.74%199.74M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.69M1.69MNew191.85M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.69M-36.66K-2.12%191.85M
ACADIAN ASSET MANAGEMENT LLC1.66M-235.82K-12.41%188.71M
LEGAL & GENERAL GROUP PLC1.61M62.79K+4.07%182.05M
FIRST TRUST ADVISORS LP1.59M87.20K+5.81%180.02M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC1.51M-32.19K-2.09%171.03M

Insights

Revenue by product
PeriodValue
FY2012J A K A F I: 3700000.0
FY2013J A K A F I: 28300000.0
FY2014J A K A F I: 49000000.0
FY2016I C L U S I G: 29600000.0, J A K A F I: 852800000.0
FY2017I C L U S I G: 66900000.0, J A K A F I: 1100000000.0
FY2018I C L U S I G: 79936000.0, J A K A F I: 1581658000.0, Milestone And Contract Revenue: 180000000.0, Olumiant Royalty: 40086000.0
FY2019I C L U S I G: 89954000.0, J A K A F I: 1910881000.0, Milestone And Contract Revenue: 77500000.0, Olumiant Royalty: 80424000.0
FY2020I C L U S I G: 105002000.0, J A K A F I: 2215752000.0, Milestone And Contract Revenue: 205000000.0, Olumiant Royalty: 110920000.0, PEMAZYRE Royalty Revenues: 25884000.0, Tabrecta Royalty Revenues: 4144000.0
FY2021I C L U S I G: 4668000.0, J A K A F I: 337991000.0, M I N J U V I: 68531000.0, Milestone And Contract Revenue: 95000000.0, Olumiant Royalty: 220875000.0, OPZELURA: 4910000.0, PEMAZYRE Royalty Revenues: 109395000.0, Tabrecta Royalty Revenues: 10389000.0
FY2022I C L U S I G: 105838000.0, J A K A F I: 2740800000.0, M I N J U V I: 19654000.0, Milestone And Contract Revenue: 165000000.0, Olumiant Royalty: 134547000.0, OPZELURA: 128735000.0, PEMAZYRE Royalty Revenues: 84650000.0, Tabrecta Royalty Revenues: 15411000.0
FY2024I C L U S I G: 114319000.0, J A K A F I: 3210947000.0, M I N J U V I: 119236000.0, Milestone And Contract Revenue: 43000000.0, Olumiant Royalty: 135572000.0, OPZELURA: 508293000.0, PEMAZYRE Royalty Revenues: 83919000.0, Tabrecta Royalty Revenues: 22746000.0, ZYNYZ: 3185000.0
FY2025I C L U S I G: 134071000.0, J A K A F I: 3550244000.0, M I N J U V I: 144578000.0, Milestone And Contract Revenue: 150000000.0, Olumiant Royalty: 144600000.0, OPZELURA: 678455000.0, PEMAZYRE Royalty Revenues: 86727000.0, Tabrecta Royalty Revenues: 26702000.0, ZYNYZ: 66351000.0
Revenue by region
PeriodValue
FY2016Europe: 29600000.0
FY2017Europe: 66900000.0
FY2018Europe: 79900000.0
FY2019Europe: 90000000.0
FY2020Europe: 105000000.0, U [S]: 2600000000.0
FY2021Europe: 124100000.0, U [S]: 2900000000.0
FY2022Europe: 147000000.0, UNITED STATES: 3200000000.0
FY2024Europe: 260400000.0, U [S]: 4000000000.0
FY2025Europe: 323734000.0, U [S]: 4799941000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Incyte (INCY) Stock Insights

INCY$117.22+0.62 +0.54%

$23.76B

Market Cap

13.94

P/E

36.91

Forward P/E

76

Score

Price History